This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Needham analyst Mike Matson upgraded the rating for Establishment Labs Holdings Inc. (NASDAQ:ESTA) from Hold to Buy and announced a $48 price target. Establishment Labs shares closed at $34.96 on Tuesday. See how other analysts view this stock.
• Jefferies analyst Ashley Helgans upgraded PVH Corp. (NYSE:PVH) from Hold to Buy and raised the price target from $70 to $105. PVH shares closed at $80.50 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Geoff Meacham upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Neutral to Buy and raised the price target from $600 to $700. Regeneron Pharmaceuticals shares closed at $574.16 on Tuesday. See how other analysts view this stock.
• Wells Fargo analyst Stan Berenshteyn upgraded the rating for Omnicell, Inc. (NASDAQ:OMCL) from Equal-Weight to Overweight and raised the price target from $31 to $35. Omnicell shares closed at $28.00 on Tuesday. See how other analysts view this stock.
• Keybanc analyst Sophie Karp upgraded the rating for Ameren Corporation (NYSE:AEE) from Sector Weight to Overweight and announced a $103 price target. Ameren shares closed at $94.32 on Tuesday. See how other analysts view this stock.

Considering buying PVH stock? Here’s what analysts think:

Read This Next:

• Jim Cramer Is ‘OK’ With Harrow, Recommends Buying This Energy Stock

Photo via Shutterstock